The study findings may help guide decision-making for clinicians caring for patients who receive hemodialysis or kidney transplant with severe secondary hyperparathyroidism.
The effect of cholecalciferol supplementation on parathyroid hormone levels and bone loss at the lumbar spine in kidney transplant recipients was studied in a placebo-controlled trial.
Purpura and ulcers were the most frequent form of clinical presentation of calciphylaxis.
Study findings suggest serum phosphate is a negative modulator of calcium receptor activation.
A recent findings, if validated, may partly explain inter-individual differences in the response to cinacalcet treatment for secondary hyperparathyroidism.
Ultrasound-guided radiofrequency ablation may result in a shorter hospital stay compared with parathyroidectomy.
Elevated parathyroid hormone has been reported as a potential risk factor for cognitive impairment.
Hungry bone syndrome occurs in 1 of 5 patients after parathyroidectomy for secondary hyperparathyroidism of renal origin, a study found.
Magnesium homeostasis in CKD-MBD been the subject of increasing attention because it plays an important role in the pathophysiology of cardiovascular disease and bone health, according to investigators.
Paricalcitol and/or calcimimetic use is associated with improved survival in patients with COVID-19 receiving maintenance hemodialysis, a study found.